2024-10-02T09:49:54-05:00 2023-12-31 390859910 BAKER TILLY ADVISORY GROUP LP 66 HUDSON BLVD E SUITE 2200 NEW YORK NY 10001 990 2023-01-01 061559393 GLOBAL LYME ALLIANCE INC GLOB 2039691333 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 LAURA MACNEILL CEO 2039691333 2024-09-30 1 0 X PATRICK YU CPA P00675982 2126976900 2024-09-30 2023 2024-10-15 13:58:12Z X LAURA MACNEILL 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 3656889 0 X GLOBALLYMEALLIANCE.ORG X 1999 CT GLOBAL LYME ALLIANCE FUNDS RESEARCH, EDUCATION & AWARENESS FOR LYME & TICK-BORNE DISEASES. 28 28 10 532 0 0 2975690 3325594 93925 100000 33630 93841 -248536 -298420 2854709 3221015 872859 960114 0 0 934019 1138978 0 0 499148 914989 1065887 2721867 3164979 132842 56036 3843093 3957959 719053 777883 3124040 3180076 X GLOBAL LYME ALLIANCE IS THE LEADING NONPROFIT DEDICATED TO CONQUERING LYME AND OTHER TICK-BORNE DISEASES. OUR MISSION: CURE LYME AND OTHER TICK-BORNE DISEASES THROUGH INNOVATIVE RESEARCH, AWARENESS, AND EMPOWERING THE PATIENT VOICE. 0 0 1454657 0 100000 GLOBAL LYME ALLIANCE (GLA) HAS A STRONG TRACK RECORD OF PROGRAM SERVICE ACCOMPLISHMENTS IN THREE MAJOR AREAS, MEASURED BY EXPENSES: RESEARCH ADVANCEMENTS: GLA INVESTS IN RESEARCH, DRIVING SIGNIFICANT PROGRESS IN LYME AND TICK-BORNE DISEASE STUDIES. THEIR CONTRIBUTIONS INCLUDE GROUNDBREAKING WORK IN DIAGNOSTICS, TREATMENT, AND UNDERSTANDING OF LYME BACTERIA. NOTABLE ACHIEVEMENTS COMPRISE CHARACTERIZING CHRONIC LYME DISEASE, GENOME SEQUENCING OF BORRELIA BURGDORFERI STRAINS, UNCOVERING ANTIBIOTIC RESISTANCE MECHANISMS, AND DOCUMENTING IMMUNE DYSFUNCTION IN PATIENTS. RECENT DISCOVERIES INCLUDE THE ROLE OF CELL WALL-DEFICIENT FORMS (L-FORMS) IN CHRONIC INFECTIONS, POTENTIALLY AIDING EARLY LYME DISEASE CURE.PATIENT SUPPORT: GLA IS COMMITTED TO AIDING PATIENTS, CAREGIVERS, AND LOVED ONES AFFECTED BY THESE DISEASES. THEY OFFER VARIOUS SUPPORT PROGRAMS, SUCH AS ACCESS TO SPECIALISTS, FINANCIAL ASSISTANCE INFORMATION, CLINICAL TRIAL OPPORTUNITIES, EMOTIONAL SUPPORT MENTORSHIP, AND EDUCATIONAL MATERIALS. THEIR HOLISTIC APPROACH ADDRESSES PATIENTS AND FAMILIES' CHALLENGES COMPREHENSIVELY.KNOWLEDGE AND AWARENESS: GLA'S RESEARCH AND EDUCATIONAL INITIATIVES HAVE PLAYED A PIVOTAL ROLE IN ENHANCING UNDERSTANDING AND AWARENESS OF LYME AND TICK-BORNE DISEASES. THEIR FUNDING OF STUDIES CONNECTING LYME DISEASE TO PSYCHIATRIC DISORDERS HAS BROADENED AWARENESS OF THE DISEASES' IMPACT ON PATIENTS' WELL-BEING. MOREOVER, GLA'S DEDICATION TO SHARING EDUCATIONAL RESOURCES AND CLINICAL TRIAL INFORMATION EMPOWERS THE COMMUNITY TO MAKE INFORMED HEALTH DECISIONS. 960114 960114 0 GLOBAL LYME ALLIANCE CONTINUES TO ADVANCE THE RESEARCH AND SCIENCE FOR LYME AND OTHER TICK-BORNE DISEASES THROUGH ITS ROBUST RESEARCH GRANT PROGRAM. GLA'S SCIENTIFIC ADVISORY BOARD (SAB), COMPRISED OF DISTINGUISHED RESEARCHERS IN MULTIDISCIPLINARY FIELDS IN LYME AND TICK-BORNE DISEASE, PROVIDES STRATEGIC GUIDANCE TO GLOBAL LYME ALLIANCE IN ITS REVIEW AND AWARD PROCESS TO ADVANCE RESEARCH AT LEADING INSTITUTIONS WITH A GOAL OF IMPROVING DIAGNOSTICS AND TREATMENT OF LYME AND OTHER TICK-BORNE ILLNESSES.AS THE LEADING PATIENT VOICE LYME NON-PROFIT MEASURED BY OUR AUDIENCE SHARE, GLA GETS INPUT FROM OUR MEDICAL ADVISORY BOARD AND PATIENT ADVOCATES TO DRIVE RESEARCH DISCOVERY; GLA BRIDGES THE GAP BETWEEN PATIENT AND RESEARCH TO INFORM WHERE SCIENCE NEEDS TO GO TO FIND A CURE. 2414771 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 20 0 10 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 28 28 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 AL AR CA FL GA HI IL KS KY MA MD MI MN MS NC NH NJ NM NY OR PA RI SC TN UT VA WI WV X X X JENNIFER KATRITOS FINANCE DIRECTOR 2039691333 1700 EAST PUTNAM AVE SUITE 400 GREENWICH CT 068701366 PAUL ROSS CHAIRMAN 10.00 0.00 X X 0 0 0 DEBORAH SICILIANO VICE CHAIR 2.00 0.00 X X 0 0 0 DIANE BLANCHARD VICE CHAIR 4.00 0.00 X X 0 0 0 CHARLES BALDUCCI VICE CHAIR 2.00 0.00 X X 0 0 0 JANET VACCARO SECRETARY 4.00 0.00 X X 0 0 0 HENRY DOSCH TREASURER 4.00 0.00 X X 0 0 0 ROBERT KOBRE DIRECTOR 4.00 0.00 X 0 0 0 NANCY DEL GENIO DIRECTOR 10.00 0.00 X 0 0 0 DAVID NOLAN DIRECTOR 2.00 0.00 X 0 0 0 EDWARD O'CONNELL DIRECTOR 2.00 0.00 X 0 0 0 KAREN PEETZ DIRECTOR 2.00 0.00 X 0 0 0 DANA MCAVITY DIRECTOR (UNTIL 9/1/2023) 2.00 0.00 X 0 0 0 BRETT KRISTOFF DIRECTOR 2.00 0.00 X 0 0 0 LORRIE NADEL DIRECTOR 2.00 0.00 X 0 0 0 RIDGWAY BARKER DIRECTOR 2.00 0.00 X 0 0 0 CHRIS CORRINET DIRECTOR 2.00 0.00 X 0 0 0 DAVID GERSTNER DIRECTOR 2.00 0.00 X 0 0 0 JULIA KNOX-COMEAU DIRECTOR 2.00 0.00 X 0 0 0 STEVE LEFKOWITZ DIRECTOR 2.00 0.00 X 0 0 0 LEWIS LEONE DIRECTOR 2.00 0.00 X 0 0 0 STEVEN MARTIN DIRECTOR 2.00 0.00 X 0 0 0 NORMA RUSSO DIRECTOR 2.00 0.00 X 0 0 0 ALEXANDER TISCH DIRECTOR 2.00 0.00 X 0 0 0 ERIN WALKER DIRECTOR 2.00 0.00 X 0 0 0 AZIZ SYRIANI DIRECTOR 2.00 0.00 X 0 0 0 BRENT PATRY DIRECTOR 2.00 0.00 X 0 0 0 KAREN KELLY DIRECTOR 2.00 0.00 X 0 0 0 MACKENZIE VATH DIRECTOR 2.00 0.00 X 0 0 0 ROSE ANASTASIO DIRECTOR 2.00 0.00 X 0 0 0 LAURA MACNEILL CHIEF EXECUTIVE OFFICER 40.00 0.00 X 237596 0 0 TIMOTHY SELLATI CHIEF SCIENTIFIC OFFICER 40.00 0.00 X 233888 0 35278 STEVEN PECOCK DIRECTOR OF DEVELOPMENT 40.00 0.00 X 137500 0 0 LINDSY SWIFT DIRECTOR OF MKTG & COMM 40.00 0.00 X 106720 0 0 715704 0 35278 4 0 1 0 0 1413691 1911903 33875 3325594 FEE FOR SERVICE 541700 100000 100000 100000 93841 93841 137454 1413691 435874 -298420 -298420 3221015 100000 0 -204579 960114 960114 491389 459826 9469 22094 564458 303954 27398 233106 1500 1500 6117 765 765 4587 75514 54370 3021 18123 46725 46725 244291 18254 107036 119001 84327 35369 20014 28944 115508 83166 3465 28877 40712 16952 16518 7242 53556 53556 26184 18853 785 6546 13027 9379 391 3257 AWARENESS 292027 270168 21859 CLINICAL STUDIES/OTHER 124650 124650 MISCELLANEOUS EXPENSE 12850 2481 5869 4500 LICENSE FEES & PERMITS 7982 7982 4048 2914 122 1012 3164979 2414771 251060 499148 852688 1020815 2346964 1572935 60000 761869 7518 25000 200000 65606 64488 228890 225696 29378 3194 156616 492791 124323 16867 3843093 3957959 69848 121513 552500 656370 96705 0 719053 777883 X 2458077 1695593 665963 1484483 3124040 3180076 3843093 3957959 56036 0 X 0 1 X 1 0 X 5180006 2861182 2734537 2975690 3325594 17077009 5180006 2861182 2734537 2975690 3325594 17077009 1550721 15526288 49812 13537 1206 33630 93841 192026 169804 151430 137454 458688 17727723 254450 0.87580 0.89990 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: FUNDRAISING INCOME - 2019 AMOUNT: $ 169,804. 2022 AMOUNT: $ 151,430. 2023 AMOUNT: $ 137,454. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 228890 225696 3194 3194 INVESTMENT IN THIRD PARTY 492791 C 492791 X 3247485 26470 26470 3221015 0 3221015 3191449 26470 26470 3164979 0 3164979 PART X, LINE 2: MANAGEMENT HAS EVALUATED GLA'S TAX POSITIONS AND CONCLUDED THAT GLA HAD NOT TAKEN ANY UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF FINANCIAL ACCOUNTING STANDARDS BOARD ("FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") NO. 740. GLA GLOBAL GALA 1334399 1251244 83155 179747 165127 27721 GOLF OUTING 216746 162447 54299 50982 12297 1551145 1413691 137454 179747 50982 165127 40018 435874 -298420 1 UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 500 SOUTH LIMESTONE 109 KINKEAD HALL LEXINGTON KY 405260001 616033693 501(C)(3) 75000 0 RESEARCH THE CHILDREN'S HOSPITAL CORPORATION BOSTON CHILDREN'S HOSPITAL PO BOX 414413 BOSTON MA 02241 042774441 501(C)(3) 175000 0 RESEARCH TULANE UNIVERSITY 6823 ST CHARLES AVE NEW ORLEANS LA 70118 720423889 501(C)(3) 177627 0 RESEARCH TEXAS A&M UNIVERSITY 400 HARVEY MITCHELL PARKWAY SOUTH COLLEGE STATION TX 77840 742907553 501(C)(3) 175000 0 RESEARCH TUFTS COLLEGE 169 HOLLAND STREET SOMERVILLE MA 02144 042103634 501(C)(3) 257487 0 RESEARCH COLUMBIA UNIVERSITY 630 WEST 168TH STEET BOX 49 NEW YORK NY 100323702 135598093 501(C)(3) 100000 0 RESEARCH 6 0 PART I, LINE 2: THE ORGANIZATION REQUIRES PROGRESS UPDATES FROM THE RECIPIENTS IN ACCORDANCE WITH THE WRITTEN GRANT AGREEMENTS THAT ARE SIGNED BY THE RECIPIENTS. X X X X 0 0 0 0 0 0 0 1 0 TIMOTHY SELLATI CHIEF SCIENTIFIC OFFICER 221388 0 5000 0 7500 0 0 0 35278 0 269166 0 0 0 LAURA MACNEILL CHIEF EXECUTIVE OFFICER 227596 0 0 0 10000 0 0 0 0 0 237596 0 0 0 PART I, LINE 7 THE EXECUTIVE TEAM'S BONUSES ARE BASED ON MEETING GOALS AND OBJECTIVES AS DETERMINE BY THE EXECUTIVE COMMITTEE OF THE BOARD, WITH THE APPROVAL OF THE BOARD OF DIRECTORS AT THE BEGINNING OF EACH YEAR. THE AMOUNT OF THE BONUS IS REVIEWED BY THE EXECUTIVE COMMITTEE AND RECOMMENDED TO THE BOARD. X 2 33875 NYSE 0 0 1 0 PART I, COLUMN (B): THE NUMBER ON PART I, COLUMN B REPRESENTS THE NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY BOTH MANAGEMENT AND THE FINANCE COMMITTEE. THE FORM 990 IS THEN DISTRIBUTED TO THE FULL BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C CONFLICTS OF INTERESTS ARE AFFIRMED ANNUALLY IN WRITING. FURTHERMORE, A DIRECTOR OR OFFICER SHALL DISCLOSE A CONFLICT OF INTEREST (A) PRIOR TO VOTING ON OR OTHERWISE DISCHARGING HIS/HER DUTIES WITH RESPECT TO ANY MATTER INVOLVING THE CONFLICT WHICH COMES BEFORE THE BOARD OR ANY COMMITTEE; (B) PRIOR TO ENTERING INTO ANY CONTRACT OR TRANSACTION INVOLVING THE CONFLICT; AND (C) AS SOON AS POSSIBLE AFTER THE DIRECTOR OR OFFICER LEARNS OF THE CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION'S EXECUTIVE COMMITTEE DETERMINES COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER AND/OR OTHER OFFICERS AND KEY EMPLOYEES BY DOING RESEARCH IN THE MARKETPLACE FOR COMPARABLE POSITIONS. THE BOARD OF DIRECTORS APPROVES COMPENSATION FOR EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC AT GLA.ORG AND UPON REQUEST. PART VI, SECTION A, LINE 1(A) THE BOARD OF DIRECTORS HAS DELEGATED BROAD AUTHORITY TO THE EXECUTIVE COMMITTEE TO RUN THE DAILY OPERATIONS OF THE ORGANIZATION.